Paragon 28 Inc

Paragon 28 — Investor Presentation (March 2022)

37 slides from Paragon 28's investor presentation, Mar 17, 2022

  1. Slide 1: Foot & Ankle Specialists March 2022

    Foot & Ankle Specialists March 2022 http://www.enduringjourneys.com/uploads/north-225.jpg

  2. Slide 2: Forward-looking statements

    2 CONFIDENTIAL Except for the historical information contained herein, the matters set forth in this presentation are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Paragon 28, Inc.

  3. Slide 3: Proven Leadership Team

    3 CONFIDENTIAL Proven Leadership Team Albert DaCosta President, CEO & Co-Founder Steve Deitsch Steve Deitsch Chief Financial Officer Frank Bono CTO, Co-Founder, and Board Director Matt Jarboe Chief Commercial Officer Jonathan Friedman General Counsel

  4. Slide 4: Paragon Investment Highlights

    4 CONFIDENTIAL Paragon 28 Investment Highlights Large ($4.3B), fast - growing (7% CAGR), and underdeveloped F&A market Unique culture and passion…F&A specialists Total solutions provider and exclusive focus on F&A 73 product systems on market and 30+ products in development Proven commercial model w

  5. Slide 5: Our Mission is to Continuously Improve Patient Lives

    5 CONFIDENTIAL Our Mission is to Continuously Improve Patient Lives p28(R) par.a.gon: a model of excellence or perfection twen.ty.eight: number of bones in the human foot; a perfect number Our mission is to continuously improve the outcomes and experiences of patients suffering from foot and ankle c

  6. Slide 6: Foot & Ankle Is the Fastest Growing Market in Orthopedics

    6 CONFIDENTIAL Foot & Ankle Is the Fastest Growing Market in Orthopedics CAGR:~7% $4.3 2021 $5.6 2025 ($ billions) Key Macro Market Drivers Aging population Increased desire to lead more active lifestyle Increased incidence of obesity and diabetes Surgeon specialization The Foot and Ankle market is

  7. Slide 7: U.S. Foot & Ankle Market Dynamics

    7 CONFIDENTIAL U.S. Foot & Ankle Market Dynamics Foot & Ankle Is Concentrated Among 3 Large Med-tech Incumbents U.S. Foot & Ankle Market 2021E $2.3B Stryker 28% -32% DePuy Synthes 12% -15% Arthrex 12% -15% Other(1) 38% Paragon 28 5% Significant opportunity for P28 to gain additional market share •Ex

  8. Slide 8: Global Market by Segment

    8 CONFIDENTIAL Global Market by Segment 2021E Global Foot & Ankle Market Fracture Fixation31% Bunions 22% (2) Orthobiologics 13% Hammertoe 11% Ankle 10% Flatfoot 9% Charcot 4% Our portfolio is highly diversified and represented in all sub-markets (1)Ankle includes all non-fracture ankle conditions s

  9. Slide 9: Foot & Ankle Consists of Several Distinct Existing Sub-markets

    9 CONFIDENTIAL Foot & Ankle Consists of Several Distinct Existing Sub-markets Fracture Fixation $1,330 $1,600 2021 2025 Bunions $930 $1,340 2021 2025 Hammertoe $460 $680 2021 2025 Orthobiologics(2) $550 $710 2021 2025 PCFD or Flatfoot $360 $410 2021 2025 Charcot Foot $190 $220 2021 2025 Ankle(1) $43

  10. Slide 10: Paragon is Disrupting the Foot & Ankle Market

    10 CONFIDENTIAL Paragon 28 is Disrupting the Foot & Ankle Market Focused and innovative med tech companies have been disruptive in their respective markets Pure Play Disruptors Incumbents Foot & Ankle Paragon28 Stryker J&J Zimmer Biomet Smith+Nephew Spine Trauma Sports Med. Vascular Diabetes Neurost

  11. Slide 11: Why is Paragon Differentiated from the Competition?

    11 CONFIDENTIAL Why is Paragon 28 Differentiated from the Competition? •Exclusive dedication to single industry •Focus on innovation •Novel approaches & solutions •Targeted commercial strategy •Broad portfolio of solutions to address all patients and complexities •Array of options for varying comple

  12. Slide 12: Opportunities to Improve Foot & Ankle Outcomes

    12 CONFIDENTIAL Opportunities to Improve Foot & Ankle Outcomes (1)Source: NIH -https://pubmed.ncbi.nlm.nih.gov/22049859/#:~:text=Irrespective%20of%20the%20implant%2C%20the,and%2043.5%25%20after%2010%20yea rs (2)Source: Hip and knee -https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528048/ Exclusive foc

  13. Slide 13: U.S. Commercial Snapshot

    13 CONFIDENTIAL U.S. Commercial Snapshot Our Commercial Team Markets Our Solutions to Hospitals Physicians Patients (DTC Marketing) 206 Producing Sales Reps(1) Foot & Ankle Surgeons ..~2,400 orthopedic surgeons who specialize in foot and ankle ..~18,000 podiatrists in the U.S. (Estimated 50% surgica

  14. Slide 14: Global Commercial Infrastructure Built to Drive Growth

    14 CONFIDENTIAL Global Commercial Infrastructure Built to Drive Growth A Leading Commercial Organization Competitive team of professionals with extensive experience in foot and ankle Clinically Focused Sales Team Sales representatives have clinical expertise and are trusted advisors to foot and ankl

  15. Slide 15: How We Will Drive Expansion of Market Share

    15 CONFIDENTIAL How We Will Drive Expansion of Market Share Continuous flow of new, innovative technologies Leverage Smart 28 initiatives to improve patient outcomes Expand commercial teams and infrastructure globally Expand customer base and deepen existing customer relationships Actively evaluate

  16. Slide 16: Paragon Financial Profile

    16 CONFIDENTIAL Paragon 28 Financial Profile $19.8 $34.8 $55.5 $84.2 $106.3 $26.8 $33.1 $169.0 $18.9 $35.7 $30.3 $35.9 $35.1 $42.8 2015 2016 2017 2018 2019 2020 2021 2022 Q1 Q2 Q3 Q4 $111.0 $147.5 1 (1) 2022 revenue guidance of $167M to $171M issued on March 8, 2022 Net Revenue Growth •40%CAGR from

  17. Slide 17: Paragon Recap

    17 CONFIDENTIAL Paragon 28 Recap Large ($4.3B), fast-growing (7% CAGR), and underdeveloped F&A market Unique culture and passion... F&A specialists Total solutions provider and exclusive focus on F&A 73 product systems on market and 30+ products in development Proven commercial model with clinical a

  18. Slide 18: Appendix

    Appendix

  19. Slide 19: Paragon Solutions Strategy

    19 CONFIDENTIAL Paragon 28 Solutions Strategy Broad Product Portfolio Robust Pipeline Smart28TM Advanced Technologies Ecosystem 73 product systems 9,100 SKUs (incl. 1,300 instruments) 30+ products in development 26 product launches expected in next 24 months Advanced technology to improve solutions

  20. Slide 20: Smart28 Ecosystem Will Improve Patient Outcomes

    20 CONFIDENTIAL Smart28 Ecosystem Will Improve Patient Outcomes and Further P28 Leadership Position What is Smart28? Our initiative to modernize and improve all aspects of Foot + Ankle treatments by utilizing advanced technologies Smart28 Mission Improved and reproducible outcomes Increased patient

  21. Slide 21: Disior - The Perfect Partner for our Smart Ecosystem

    21 CONFIDENTIAL Disior-The Perfect Partner for our Smart 28 Ecosystem Intra-operative Support Post-operative Evaluation Pre-operative Planning Auto-segmentation and surgical planning tool 3D modeling to better address complex cases Accelerates research and development efforts to improve Foot & Ankle

  22. Slide 22: Disior Integration into Smart28

    22 CONFIDENTIAL Disior Integration into Smart 28 Phase 1 –Research & Development •Accelerate groundbreaking research projects Phase 2 –Commercial Launch Phase 3 –Outcome Optimization •Expand surgical planning capabilities of Disior •Patient Specific Implant / Instrument integration •Offer Disior pla

  23. Slide 23: Disior Provides Foundation for Smart28

    23 CONFIDENTIAL Disior Provides Foundation for Smart28 Disior Synergies Research & Development •Accelerate R & D projects •Scalability of patient specific surgical support Revenue Opportunities •Improve surgical outcomes •Optimized solutions, proven results, more customers Strategic Surgeon Network

  24. Slide 24: Paragon Selected Product Systems

    24 CONFIDENTIAL Paragon 28 Selected Product Systems Gorilla Plating Comprehensive plate options with unique, custom instrumentation Baby Gorilla Mini Plating Comprehensive plating options with unique, custom instrumentation Screw & Orthobiologics Comprehensive offering of cannulated & solid screws P

  25. Slide 25: Paragon Full Range of Foot and Ankle Solutions

    25 CONFIDENTIAL Paragon 28 Full Range of Foot and Ankle Solutions Paragon 28 Full Range of Foot and Ankle Solutions 1 2 3 4 5 6 Ankle Charcot Fracture Fixation Hallux Valgus Hammertoe Flatfoot Biologics Ankle Fusion and Deformity Internal Fixation Foot Fracture Shaft Hammertoe .. Preserve bone wedge

  26. Slide 26: Selected Examples of Paragon Solutions

    Selected Examples of Paragon 28 Solutions Total Ankle 1 Replacement Solution 2 Bunion Solutions - Optionality For All Degrees of Deformity 3 Syndesmotic Ankle Fixation Solution .. 12 to 38% tibial component loosening .. Overly constrained articulation components in presence of imperfect alignment ..

  27. Slide 27: Truly Making a Difference for Foot & Ankle Patients

    27 CONFIDENTIAL Truly Making a Difference for Foot & Ankle Patients ..We believe a superior approach to treat avascular necrosis of ankle joint ..Utilizes CT scan to create patient specific solution ..Demonstrates improved clinical outcomes Patients Who Received Patient Specific Talus Spacer Showed

  28. Slide 28: International Presence & Market Development

    28 CONFIDENTIAL International Presence & Market Development Growth Strategy TARGET countries where Paragon 28 can maximize strong ASP + Margins BUILD experienced international commercial team in sales & marketing, training + distribution LEVERAGE opportunities to improve distributor network through

  29. Slide 29: Examples of Paragon Solutions

    29 CONFIDENTIAL Examples of Paragon 28 Solutions P28 Bunion Solutions –Optionality For All Degrees of Deformity Ankle Solution Case Study Fracture Fixation Solution Case Study

  30. Slide 30: P28 Total Ankle Replacement Solution

    30 CONFIDENTIAL Addresses all factors believed to contribute to loosing Addresses accumulation of stress at corners of components to radiate more evenly across arched geometry P28 Total Ankle Replacement Solution Problem Solution Lightbulb and gear with solid fill Thumbs Down with solid fill 12 to 3

  31. Slide 31: P28 Total Ankle Replacement Solution

    31 CONFIDENTIAL P28 Total Ankle Replacement Solution Conical Axis is centered on the natural rotation of the joint and ligaments Salto Talaris Ankle Anatomical Articulating Surface

  32. Slide 32: P28 Total Ankle Replacement Solution

    32 CONFIDENTIAL P28 Total Ankle Replacement Solution

  33. Slide 33: P28 Bunion Solutions – Optionality For All Degrees of Deformity

    33 CONFIDENTIAL P28 Bunion Solutions –Optionality For All Degrees of Deformity Problem Solution •No two bunions are alike •~3% to 70% revision rates for certain Bunion osteotomies •No consensus clinical approach We offer a comprehensive portfolio to address bunion of varying severities and each pati

  34. Slide 34: P28 Bunion Solution - PROMO

    34 CONFIDENTIAL Rotation Angles 10–19 20–29 30–39 IM Angles 8–10 38 28 23 11–12 47 33 28 13–14 55 38 33 15–17 55 42 38 18–20 55 47 42 ..Simultaneous correction of IM angle and rotational deformity ..Single oblique osteotomy with no wedge resection ..Joint sparing procedure with powerful correction .

  35. Slide 35: P28 Bunion Solution – Lapidus Nail For Severe Bunion

    35 CONFIDENTIAL P28 Bunion Solution –Lapidus Nail For Severe Bunion Phantom Intramedullary Nail System for Treatment of Severe Hallux Valgus ..Solution for severe bunion candidates ..A novel dedicated intramedullary device designed specifically for use in bunion surgery ..Fuses the first TMT joint b

  36. Slide 36: P28 Syndesmotic Ankle Fixation Solution

    36 CONFIDENTIAL Engineered screw to release initial rigid fixation where soft tissue has initiated healing Optimal range to best restore anatomic function of environment R3LEASEscrew head designed to fit perfectly in ankle fracture plating system Pipeline:R3ACTfixation screw (image below) P28 Syndes

  37. Slide 37: P28 Syndesmotic Ankle Fixation Solution

    37 CONFIDENTIAL P28 Syndesmotic Ankle Fixation Solution

Paragon 28 — Investor Presentation (March 2022) on 6ix